Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia : a phase II SWO...
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia : a phase II SWOG TRIAL 9706
About this item
Full title
Author / Creator
HUSSEIN, M. A , GUNDACKER, H , HEAD, D. R , ELIAS, L , FOON, K. A , BOLDT, D. H , DOBIN, S. M , DAKHIL, S. R , BUDD, G. T and APPELBAUM, F. R
Publisher
London: Nature Publishing
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing
Subjects
More information
Scope and Contents
Contents
B-cell chronic lymphocytic leukemia (CLL) accounts for 95% of chronic leukemia cases and 25% of all leukemia. Despite the prevalence of CLL, progress in its treatment has been only modest over the past three decades. Based upon the ability of fludarabine to produce high-grade remissions especially among patients with low initial tumor mass, and the...
Alternative Titles
Full title
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia : a phase II SWOG TRIAL 9706
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2645715408
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2645715408
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/sj.leu.2403940
